Active	Status	Sponsor type	Region	Phase	Filter
4 Active 2 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Reagan, Rovena
NCT05303636: LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women	Recruiting	4	1710	US	LF111 (drospirenone 4 mg oral tablet) or drospirenone (DRSP) 3.5 mg chewable tablet	Insud Pharma, Chemo Research	Change in Bone Mineral Density, Bone Loss	07/26	03/27
NCT05264506: Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive	Terminated	3	2007	US	NOMAC-E2 COC, Nomegestrol acetate / estradiol	Organon and Co, IQVIA Inc., OSTAtistics	Contraception	01/24	01/24
NCT04457076: Evaluation of the Efficacy, Safety, and Tolerability of LevoCept	Not yet recruiting	3	1525	US	LevoCept	Sebela Women's Health Inc., PRA Health Sciences	Contraception, Women at Risk for Pregnancy	01/29	01/31
NCT01429389: Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy	Recruiting	N/A	2000	Canada, US		Sequenom, Inc.	Down Syndrome, Fetal Aneuploidy	12/25	03/26